Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer
Metrics: HTML 1120 views | ?
Bo Su1,2,3,*, Jian Su1,2,4,*, Ying Zeng1,2,*, Fang Liu1,2, Hong Xia1,2, Yan-Hua Ma1,2, Zhi-Gang Zhou1,2, Shuo Zhang1,2, Bang-Min Yang1,2, You-Hua Wu1, Xi Zeng1,2, Xiao-Hong Ai1, Hui Ling1,2, Hao Jiang1, Qi Su1,2
1Center for Gastric Cancer Research of Hunan Province, First Affiliated Hospital, University of South China, Hengyang, 421001 Hunan, China
2Key Laboratory of Cancer Cellular and Molecular Pathology of Hunan Provincial University, Cancer Research Institute, University of South China, Hengyang, 421001 Hunan, China
3Key Laboratory for Pharmacoproteomics of Hunan Provincial University, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, 421001 Hunan, China
4Department of Pathology, Second Affiliated Hospital, University of South China, Hengyang, 421001 Hunan, China
*These authors have contributed equally to this work
Hao Jiang, e-mail: firstname.lastname@example.org
Qi Su, e-mail: email@example.com
Keywords: diallyl disulfide, LIMK1, gastric cancer cell epithelial-mesenchymal transition, invasion, proliferation
Received: October 21, 2015 Accepted: January 24, 2016 Published: February 8, 2016
Diallyl disulfide (DADS) has been shown to have multi-targeted antitumor activities. We have previously discovered that it has a repressive effect on LIM kinase-1 (LIMK1) expression in gastric cancer MGC803 cells. This suggests that DADS may inhibit epithelial-mesenchymal transition (EMT) by downregulating LIMK1, resulting in the inhibition of invasion and growth in gastric cancer. In this study, we reveal that LIMK1 expression is correlated with tumor differentiation, invasion depth, clinical stage, lymph node metastasis, and poor prognosis. DADS downregulated the Rac1-Pak1/Rock1-LIMK1 pathway in MGC803 cells, as shown by decreased p-LIMK1 and p-cofilin1 levels, and suppressed cell migration and invasion. Knockdown and overexpression experiments performed in vitro demonstrated that downregulating LIMK1 with DADS resulted in restrained EMT that was coupled with decreased matrix metalloproteinase-9 (MMP-9) and increased tissue inhibitor of metalloproteinase-3 (TIMP-3) expression. In in vitro and in vivo experiments, the DADS-induced suppression of cell proliferation was enhanced and antagonized by the knockdown and overexpression of LIMK1, respectively. Similar results were observed for DADS-induced changes in the expression of vimentin, CD34, Ki-67, and E-cadherin in xenografted tumors. These results indicate that downregulation of LIMK1 by DADS could explain the inhibition of EMT, invasion and proliferation in gastric cancer cells.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.